Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
13,009,799
-
Shares change
-
+13,009,620
-
Total reported value, excl. options
-
$406,683,468
-
Value change
-
+$406,677,512
-
Number of buys
-
69
-
Price
-
$31.26
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2021
70 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q2 2021.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,009,799 shares
of 63,223,223 outstanding shares and own 20.58% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (1,772,789 shares), PERCEPTIVE ADVISORS LLC (1,235,886 shares), NEXT CENTURY GROWTH INVESTORS LLC (994,351 shares), VANGUARD GROUP INC (956,160 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (771,264 shares), BlackRock Inc. (682,341 shares), JANUS HENDERSON GROUP PLC (672,559 shares), FMR LLC (615,500 shares), JENNISON ASSOCIATES LLC (560,652 shares), and FEDERATED HERMES, INC. (350,000 shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.